Nuria Fernández Selected Research

Purinergic P2Y Receptors

1/2014	Purinergic component in the coronary vasodilatation to acetylcholine after ischemia-reperfusion in perfused rat hearts.
8/2012	Coronary response to diadenosine triphosphate after ischemia-reperfusion in the isolated rat heart.
6/2011	Coronary response to diadenosine tetraphosphate after ischemia-reperfusion in the isolated rat heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nuria Fernández Research Topics

Disease

18	Ischemia 10/2015 - 12/2002
4	Coronary Occlusion 05/2006 - 12/2002
4	Diabetes Mellitus 01/2004 - 02/2003
3	Hypertension (High Blood Pressure) 04/2020 - 08/2002
2	Weight Gain 03/2021 - 01/2017
2	Ulcer 12/2020 - 08/2007
2	Thrombosis (Thrombus) 01/2016 - 01/2004
2	Infections 08/2007 - 07/2007
2	Hyperemia 11/2006 - 01/2006
1	Inflammation (Inflammations) 02/2022
1	Ischemic Stroke 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Infarction (Infarctions) 01/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022
1	Stroke (Strokes) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2020
1	Insulin Resistance 04/2020
1	Myocardial Infarction 01/2020
1	Primary Hyperparathyroidism 03/2018
1	Hypersensitivity (Allergy) 01/2018
1	Obesity 01/2018
1	Noncommunicable Diseases 01/2018
1	Reperfusion Injury 10/2015
1	Birth Weight (Birth Weights) 03/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013
1	Neoplasms (Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

13	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 12/2002
13	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2014 - 08/2002
11	Endothelin-1 (Endothelin 1)IBA 06/2011 - 08/2002
9	ProstaglandinsIBA 11/2006 - 12/2002
7	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014 - 08/2002
7	Vasoconstrictor AgentsIBA 07/2010 - 12/2002
7	Meclofenamic Acid (Meclofenamate)FDA LinkGeneric 02/2008 - 12/2002
6	Vasodilator Agents (Vasodilators)IBA 01/2006 - 12/2002
5	Peptides (Polypeptides)IBA 05/2009 - 06/2003
5	Vasopressins (Vasopressin)IBA 06/2005 - 06/2003
4	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2006 - 12/2002
4	Arginine (L-Arginine)FDA Link 06/2005 - 12/2002
3	Cibacron Blue F 3GAIBA 01/2014 - 06/2011
3	Purinergic P2Y ReceptorsIBA 01/2014 - 06/2011
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 07/2010 - 11/2005
3	Cyclooxygenase InhibitorsIBA 02/2008 - 05/2004
3	Endothelins (Endothelin)IBA 02/2008 - 11/2005
3	UrocortinsIBA 06/2005 - 06/2003
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 10/2015
2	Angiotensin IIIBA 04/2020 - 05/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 03/2015
2	Purinergic Receptors (Receptors, Purine)IBA 10/2015 - 01/2014
2	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 08/2012 - 02/2005
2	Glyburide (Glibenclamide)FDA LinkGeneric 08/2012 - 06/2011
2	BQ 788IBA 02/2008 - 05/2006
2	cyclo(Trp-Asp-Pro-Val-Leu)IBA 02/2008 - 05/2006
2	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2005 - 01/2004
2	arginine methyl esterIBA 02/2005 - 07/2004
2	Arginine Vasopressin (Argipressin)IBA 07/2004 - 07/2003
2	Streptozocin (Streptozotocin)FDA Link 06/2003 - 02/2003
1	LipopolysaccharidesIBA 02/2022
1	InflammasomesIBA 01/2022
1	triphenyltetrazoliumIBA 01/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	Proton Pump InhibitorsIBA 12/2020
1	Messenger RNA (mRNA)IBA 04/2020
1	CholesterolIBA 04/2020
1	Blood Glucose (Blood Sugar)IBA 04/2020
1	locust bean gum (carob)FDA Link 04/2020
1	Insulin (Novolin)FDA Link 04/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2020
1	LDL CholesterolIBA 04/2020
1	oxidized low density lipoproteinIBA 04/2020
1	AntioxidantsIBA 04/2020
1	EnzymesIBA 01/2020
1	Parathyroid Hormone (Parathormone)IBA 03/2018
1	Volatile Fatty AcidsIBA 01/2017
1	AntithrombinsIBA 01/2016
1	AnticoagulantsIBA 01/2016
1	SerpinsIBA 01/2016
1	brilliant blue (brilliant blue FCF)IBA 10/2015
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 01/2014
1	Purinergic P2X ReceptorsIBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 08/2012
1	N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphateIBA 08/2012
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 08/2012
1	diadenosine triphosphate (ApppA)IBA 08/2012
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 06/2011
1	KATP ChannelsIBA 06/2011
1	WortmanninIBA 06/2011
1	Uridine Triphosphate (UTP)IBA 06/2011
1	bisindolylmaleimide IIBA 06/2011
1	IsatinIBA 06/2011
1	diadenosine tetraphosphateIBA 06/2011
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 06/2011
1	TyramineIBA 07/2010
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 07/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2010

Therapy/Procedure

3	Therapeutics 03/2009 - 07/2007
1	Duration of Therapy 12/2020